
Adaptimmune Therapeutics (NASDAQ:ADAP) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement.
Analysts estimate that Adaptimmune Therapeutics will report an earnings per share (EPS) of $0.14.